Plenary Meeting in the Field of Medical Devices and Biomedicine

China Consensus Framework & Collaboration Session: Pan Guangcheng, President of China Pharmaceutical Industry Association introduced the general situation of China’s pharmaceutical industry, the relevant situation of the Chinese Consensus Framework for the Ethical Collaboration in the Pharmaceutical and Medical Device Sectors to the representatives, and analyzed the steps and strategies to implement the consensus framework. He pointed out that with the development of China’s economy and the increasing aging of population, Chinese people’s demand for health has generally increased rapidly, and the pharmaceutical industry has a large room for growth. Under the guidance and witness of Ministry of Industry and Information Technology, the National Health Commission, Ministry of Commerce, China Drug Administration, the State Administration of Traditional Chinese Medicine of the People’s Republic of China and other government departments, on July 6, representatives from 25 pharmaceutical, health industry associations, chambers of commerce, academic associations and foundations signed the Chinese Consensus Framework for the Ethical Collaboration in the Pharmaceutical and Medical Device Sectors jointly drafted by China Pharmaceutical Industry Association, China Chamber of Commerce for Import & Export of Medicines & Health Products and RDPAC.